{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:10:09Z","timestamp":1749485409418,"version":"3.41.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.preghy.2025.101210","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T21:11:27Z","timestamp":1743801087000},"page":"101210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypertensive disorders of pregnancy trends in the United States post aspirin recommendation guidelines"],"prefix":"10.1016","volume":"40","author":[{"given":"Mariam K.","family":"Ayyash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Rodney A.","family":"Mclaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda B.","family":"Al-Kouatly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Shaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.preghy.2025.101210_b0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.18741","article-title":"Evaluation of US State-Level Variation in Hypertensive Disorders of Pregnancy","volume":"3","author":"Butwick","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"9741","key":"10.1016\/j.preghy.2025.101210_b0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.preghy.2025.101210_b0015","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","article-title":"Etiology and pathogenesis of preeclampsia: current concepts","volume":"179","author":"Dekker","year":"1998","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101210_b0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/AOG.0000000000003885","article-title":"Early Pregnancy Blood Pressure Elevations and Risk for Maternal and Neonatal Morbidity","volume":"136","author":"Sutton","year":"2020","journal-title":"Obstet Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2025.101210_b0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198908103210604","article-title":"Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension","volume":"321","author":"Benigni","year":"1989","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.preghy.2025.101210_b0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med."},{"issue":"9575","key":"10.1016\/j.preghy.2025.101210_b0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2025.101210_b0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.preghy.2025.101210_b0045","doi-asserted-by":"crossref","unstructured":"Low-dose aspirin use during pregnancy. ACOG Committee Opinion No. 743. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;132:e44\u201352.","DOI":"10.1097\/AOG.0000000000002708"},{"issue":"7","key":"10.1016\/j.preghy.2025.101210_b0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.preghy.2025.101210_b0055","doi-asserted-by":"crossref","unstructured":"Ayyash M, Goyert G, Garcia R, Khangura R, Pitts D, Jacobsen G, Shaman M. Efficacy and Safety of Aspirin 162\u2009mg for Preeclampsia Prophylaxis in High-Risk Patients. Am J Perinatol. 2023 Jul 29. Epub ahead of print. PMID: 37516117.","DOI":"10.1055\/s-0043-1771260"},{"issue":"8898","key":"10.1016\/j.preghy.2025.101210_b0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","author":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","year":"1994","journal-title":"Lancet"},{"issue":"585","key":"10.1016\/j.preghy.2025.101210_b0065","first-page":"e1","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"402\u201314","key":"10.1016\/j.preghy.2025.101210_b0070","first-page":"33","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"141\u20136","key":"10.1016\/j.preghy.2025.101210_b0075","first-page":"34","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.preghy.2025.101210_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.preghy.2025.101210_b0085","first-page":"e1","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.preghy.2025.101210_b0090","first-page":"838","article-title":"Role of aspirin in the prevention of preeclampsia in previously hypertensive pregnant women: A Meta-Analysis","volume":"73","author":"Ashraf Jahangeer","year":"2023","journal-title":"J Pak Med Assoc."},{"issue":"7","key":"10.1016\/j.preghy.2025.101210_b0095","article-title":"Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"9","key":"10.1016\/j.preghy.2025.101210_b0100","article-title":"Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med."},{"issue":"3","key":"10.1016\/j.preghy.2025.101210_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther."},{"issue":"6","key":"10.1016\/j.preghy.2025.101210_b0110","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.preghy.2025.101210_b0115","doi-asserted-by":"crossref","unstructured":"Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011 Nov;39(6):641-52. doi: 10.1515\/jpm.2011.098. Epub 2011 Aug 17. PMID: 21848483; PMCID: PMC3213694.","DOI":"10.1515\/jpm.2011.098"},{"key":"10.1016\/j.preghy.2025.101210_b0120","doi-asserted-by":"crossref","unstructured":"Brosens I, Pijnenborg R, Vercruysse L, Romero R. The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011 Mar;204(3):193-201. doi: 10.1016\/j.ajog.2010.08.009. Epub 2010 Nov 20. PMID: 21094932; PMCID: PMC3369813.","DOI":"10.1016\/j.ajog.2010.08.009"},{"issue":"1","key":"10.1016\/j.preghy.2025.101210_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12963-018-0166-4","article-title":"Projection of the future diabetes burden in the United States through 2060","volume":"16","author":"Lin","year":"2018","journal-title":"Popul Health Metr."},{"issue":"6","key":"10.1016\/j.preghy.2025.101210_b0130","article-title":"Prevalence and control rates of hypertension in the USA: 2017-2018","volume":"31","author":"Chobufo","year":"2020","journal-title":"Int J Cardiol Hypertens."},{"key":"10.1016\/j.preghy.2025.101210_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.preghy.2022.06.004","article-title":"Change in prevalence of chronic hypertension in pregnancy after the updated ACC\/AHA hypertension guidelines","volume":"29","author":"McLaren","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"10","key":"10.1016\/j.preghy.2025.101210_b0140","article-title":"Trends in general and abdominal obesity in US adults: Evidence from the National Health and Nutrition Examination Survey (2001-2018)","volume":"6","author":"Sun","year":"2022","journal-title":"Front Public Health."},{"issue":"11","key":"10.1016\/j.preghy.2025.101210_b0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025050","article-title":"Temporal Trends in Adverse Pregnancy Outcomes in Birthing Individuals Aged 15 to 44Years in the United States, 2007 to 2019","volume":"11","author":"Freaney","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.preghy.2025.101210_b0150","doi-asserted-by":"crossref","unstructured":"SMFM Patient Safety and Quality Committee. Electronic address: smfm@smfm.org, Combs CA, Montgomery DM. Society for Maternal-Fetal Medicine Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin. Am J Obstet Gynecol. 2020 Sep;223(3):B7-B11.","DOI":"10.1016\/j.ajog.2020.06.003"},{"key":"10.1016\/j.preghy.2025.101210_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preghy.2023.09.002","article-title":"Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia","volume":"34","author":"Ayyash","year":"2023","journal-title":"Pregnancy Hypertens."},{"issue":"9","key":"10.1016\/j.preghy.2025.101210_b0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jogc.2017.04.040","article-title":"Low Rates of Aspirin Use for the Prevention of Preeclampsia","volume":"39","author":"Viguiliouk","year":"2017","journal-title":"J Obstet Gynaecol Can."},{"key":"10.1016\/j.preghy.2025.101210_b0165","doi-asserted-by":"crossref","unstructured":"Ray JG, Abdulaziz KE, Berger H; DOH-NET (Diabetes, Obesity, and Hypertension in Pregnancy Research Network). Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension. JAMA. 2022 Jan 25;327(4):388-390. doi: 10.1001\/jama.2021.22749. PMID: 35076678.","DOI":"10.1001\/jama.2021.22749"},{"key":"10.1016\/j.preghy.2025.101210_b0170","doi-asserted-by":"crossref","unstructured":"Serrano B, Bonacina E, Garcia-Ruiz I, Mendoza M, Garcia-Manau P, Garcia-Aguilar P, Gil J, Armengol-Alsina M, Fern\u00e1ndez-Hidalgo N, Sulleiro E, Castillo-Ribelles L, Maiz N, Carreras E, Suy A. Confirmation of preeclampsia-like syndrome induced by severe COVID-19: an observational study. Am J Obstet Gynecol MFM. 2023 Jan;5(1):100760. doi: 10.1016\/j.ajogmf.2022.100760. Epub 2022 Oct 1. PMID: 36195282.","DOI":"10.1016\/j.ajogmf.2022.100760"},{"key":"10.1016\/j.preghy.2025.101210_b0175","doi-asserted-by":"crossref","unstructured":"Dietz P, Bombard J, Mulready-Ward C, Gauthier J, Sackoff J, Brozicevic P, Gambatese M, Nyland-Funke M, England L, Harrison L, Farr S. Validation of selected items on the 2003 U.S. standard certificate of live birth: New York City and Vermont. Public Health Rep. 2015 Jan-Feb;130(1):60-70. doi: 10.1177\/003335491513000108. Erratum in: Public Health Rep. 2015 May-Jun;130(3):192. PMID: 25552756.","DOI":"10.1177\/003335491513000108"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T15:28:55Z","timestamp":1749482935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778925000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"alternative-id":["S2210778925000261"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101210","relation":{},"ISSN":["2210-7789"],"issn-type":[{"type":"print","value":"2210-7789"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertensive disorders of pregnancy trends in the United States post aspirin recommendation guidelines","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101210"}}